✦ LIBER ✦

Everolimus (RAD001) in the treatment of advanced renal cell carcinoma: biology and pathways

✍ Scribed by James M. G. Larkin; Rosemary E. J. Clarke; Lisa M. Pickering

Book ID: 107576785
Publisher: Springer US
Year: 2009
Tongue: English
Weight: 194 KB
Volume: 26
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-008-9154-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Everolimus in the treatment of renal cel

Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors

✍ Hiu-yan Chan; Ashley B. Grossman; Ronald M. Bukowski 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 523 KB

Temisorlimus in the treatment of advance

Temisorlimus in the treatment of advanced renal cell carcinoma

✍ Bernard J. Escudier 📂 Article 📅 2007 🏛 PAGEPress Publications 🌐 English ⚖ 121 KB

PROLONGED SURVIVAL IN RENAL TRANSPLANT R

PROLONGED SURVIVAL IN RENAL TRANSPLANT RECIPIENT WITH ADVANCED RENAL CELL CARCINOMA BY EVEROLIMUS AND SORAFENIB

✍ Prajej Ruangkanchanasetr; Bundith Kanjanapayak; Kamolwan Jungmeechoke 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB

Advances in the diagnosis and treatment

Advances in the diagnosis and treatment of renal cell carcinoma

✍ Robert O. Northway III; Chad W.M. Ritenour; Fray F. Marshall 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 83 KB

Targeted agents for the treatment of adv

Targeted agents for the treatment of advanced renal cell carcinoma

✍ Walter M. Stadler 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

A phase 2 study with a daily regimen of

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

✍ Robert J. Amato; Jaroslaw Jac; Sarah Giessinger; Somyata Saxena; James P. Willis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views